Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Myristic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 known ✓ | P17787 | 5/20 | 0.65 |
| ▸ | CHRNA4 known ✓ | P43681 | 5/20 | 0.65 |
| ▸ | BLM | P54132 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.65 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.65 |
| ▸ | CHRNA2 | Q15822 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.65 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.65 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.65 |
| ▸ | HTR3B | O95264 | 1/20 | 0.65 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.65 |
| ▸ | CHRNG | P07510 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decanoic Acid SCHEMBL31258562 | 1.00 | BLM (0.65) | BLMKDM4EALOX15CHRNB2CHRNA4 | |
| Palmitic Acid SCHEMBL31628347 | 1.00 | BLM (0.65) | BLMKDM4EALOX15CHRNB2CHRNA4 | |
| Stearic Acid SCHEMBL31628546 | 1.00 | BLM (0.65) | BLMKDM4EALOX15CHRNB2CHRNA4 | |
| Stearic Acid SCHEMBL20340266 | 1.00 | BLM (0.65) | BLMKDM4EALOX15CHRNB2CHRNA4 | |
| Dodecanoate SCHEMBL16243066 | 1.00 | BLM (0.65) | BLMKDM4EALOX15CHRNB2CHRNA4 | |
| Palmitic Acid SCHEMBL20339205 | 1.00 | BLM (0.65) | BLMKDM4EALOX15CHRNB2CHRNA4 | |
| Dodecanoate SCHEMBL16243067 | 1.00 | BLM (0.65) | BLMKDM4EALOX15CHRNB2CHRNA4 | |
| (+/-)Nicotine SCHEMBL22720654 | 1.00 | BLM (0.65) | BLMKDM4EALOX15CHRNB2CHRNA4 | |
| Nicotine SCHEMBL22720652 | 1.00 | BLM (0.65) | BLMKDM4EALOX15CHRNB2CHRNA4 | |
| Decanoic Acid SCHEMBL28723468 | 1.00 | BLM (0.65) | BLMKDM4EALOX15CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119014567-A | Orange-flavored atomized liquid and preparation method and application thereof | 深圳市卓力能技术有限公司 | 2024-11-26 | — | — | CN | claimed |
| WO-2024119535-A1 | ATOMIZATION BASE LIQUID, ATOMIZATION LIQUID AND METHOD FOR REDUCING SMALL-PARTICLE-SIZE PARTICLES OF AEROSOL | 深圳市真味生物科技有限公司 | 2024-06-13 | — | — | WO | claimed |
| CN-115736321-A | Novel atomized liquid | 深圳市真味生物科技有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115736322-A | Atomized base liquid, atomized liquid and method for reducing small-particle-size aerosol particles | 深圳市真味生物科技有限公司 | 2023-03-07 | — | — | CN | claimed |
| EP-4497339-B1 | GELS WICKS FOR VAPORIZER DEVICES | JUUL LABS INC (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20260013547-A1 | Organic-Based Nicotine Gel Compositions | JUUL LABS INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250386854-A1 | Metal Oxide-Based Gel Nicotine Compositions | JUUL LABS INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250288002-A1 | Gels Wicks for Vaporizer Devices | JUUL LABS, INC. | 2025-09-18 | — | — | US | disclosed |
| US-12389934-B2 | Organic-based nicotine gel compositions | JUUL LABS, INC. (US) | 2025-08-19 | — | — | US | disclosed |
| US-12369617-B2 | Metal oxide-based gel nicotine compositions | JUUL LABS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-12342864-B2 | Gels wicks for vaporizer devices | JUUL LABS, INC. (US) | 2025-07-01 | — | — | US | disclosed |
| US-20250151774-A1 | NICOTINE SALT FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF | JLI NATIONAL SETTLEMENT TRUST | 2025-05-15 | — | — | US | disclosed |
| US-9215895-B2 | Nicotine salt formulations for aerosol devices and methods thereof | PAX LABS, INC. (US) | 2015-12-22 | — | — | US | disclosed |
| WO-2015084544-A1 | NICOTINE LIQUID FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF | PLOOM, INC. (US) | 2015-06-11 | — | — | WO | disclosed |
| US-20150020824-A1 | NICOTINE SALT FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF | VMR PRODUCTS LLC | 2015-01-22 | — | — | US | disclosed |
| US-20140345631-A1 | NICOTINE SALT FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF | PLOOM, INC. (US) | 2014-11-27 | — | — | US | disclosed |
| EP-0283672-B1 | CIGARETTE | R.J. REYNOLDS TOBACCO COMPANY (US) | 1993-09-22 | — | — | EP | disclosed |
| US-4836224-A | CONTAINING LEVULINIC ACID | R. J. REYNOLDS TOBACCO COMPANY (US) | 1989-06-06 | — | — | US | disclosed |
| US-4830028-A | NICOTINE LEVULINATE, PH | R. J. REYNOLDS TOBACCO COMPANY (US) | 1989-05-16 | — | — | US | disclosed |
| EP-0283672-A2 | Cigarette | R.J. REYNOLDS TOBACCO COMPANY (US) | 1988-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250386854-A1 | Metal Oxide-Based Gel Nicotine Compositions | TAB1, SHC1, CALML3 | CHRNB2 98/4885CHRNA4 248/4885BLM 1891/4885 |
| US-20260013547-A1 | Organic-Based Nicotine Gel Compositions | CHRNB1, CHRNB3, CHRNA1 | CHRNB2 5/4885CHRNA4 23/4885BLM 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.